◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › 0-9 › 0241

Alibaba Health Information Technology Limited (0241) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Pharmaceutical Retailers · DATA UPDATED 2026-09-30

Alibaba Health Information Technology Limited (0241) operates in the Pharmaceutical Retailers industry and is headquartered in Causeway Bay, Hong Kong with about 1,394 employees. Its market capitalization is roughly HK$46 billion. In the fiscal year ended 2026-03-31, 0241 reported CNY 34.3B in revenue and CNY 1.9B in net income.

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in the People's Republic of China.

Interactive charts & full statements → Open the 0241 valuation workbench →

0241 Revenue & Earnings History — Annual Income Statement

Income statement2026-03-312025-03-312024-03-312023-03-312022-03-31
Total RevenueCNY 34.3BCNY 30.6BCNY 27.0BCNY 26.8B—
Gross ProfitCNY 8.2BCNY 7.4BCNY 5.9BCNY 5.7B—
Operating Income (EBIT)CNY 1.9BCNY 1.6BCNY 712MCNY 51M—
Net IncomeCNY 1.9BCNY 1.4BCNY 884MCNY 536M—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0241 Free Cash Flow History

0241 Balance Sheet History

Balance sheet2026-03-312025-03-312024-03-312023-03-312022-03-31
Total AssetsCNY 23.1BCNY 21.2BCNY 19.7BCNY 20.7B—
Total LiabilitiesCNY 5.2BCNY 4.9BCNY 5.2BCNY 5.6B—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0241 viewer.

Other Companies in Pharmaceutical Retailers

← 0240All “0-9” companies0242 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.